CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates a specific transporter in breast cancer cells that is crucial for metastasis formation. By targeting this transporter, the project aims to develop new therapeutic strategies to inhibit the spread of cancer to other organs, potentially improving treatment outcomes for patients.
Metastasis formation is the leading cause of death in cancer patients.
Thus, there is an unmet need for drugs that can prevent and/or treat systemic metastases.
We have discovered that breast cancer cells rely on a solute carrier (SLC) transporter for metastasis formation in lung and liver.
Interestingly, systemic inhibition of this SLC transporter using a therapeutic modality has likely a favorable toxicity profile because knockout mice are viable and have very few and minor phenotypic changes.…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
